Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

BACKGROUND: Treatment options for patients with advanced hepatocellular carcinoma (HCC) are often limited. In most cases, they are not amenable to local therapies including surgery or radiofrequency ablation. The multi-kinase inhibitor sorafenib has shown to increase overall survival in this patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Combs, Stephanie E, Habermehl, Daniel, Ganten, Tom, Schmidt, Jan, Edler, Lutz, Burkholder, Iris, Jäkel, Oliver, Haberer, Thomas, Debus, Jürgen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045987/
https://www.ncbi.nlm.nih.gov/pubmed/21314962
http://dx.doi.org/10.1186/1471-2407-11-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045987/
https://www.ncbi.nlm.nih.gov/pubmed/21314962
http://dx.doi.org/10.1186/1471-2407-11-67

Ejemplares similares